NCT07500805 2026-03-30
UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma
UTC Therapeutics Inc.
Phase 1 Not yet recruiting
UTC Therapeutics Inc.
Zhejiang Haichang Biotech Co., Ltd.
Merck Sharp & Dohme LLC
AccSalus Biosciences, Inc.
OncoHost Ltd.
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Power Life Sciences Inc.